These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22492623)

  • 21. New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats.
    Laurent FX; Sureau A; Klein AF; Trouslard F; Gasnier E; Furling D; Marie J
    Nucleic Acids Res; 2012 Apr; 40(7):3159-71. PubMed ID: 22156369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy.
    Osborne RJ; Lin X; Welle S; Sobczak K; O'Rourke JR; Swanson MS; Thornton CA
    Hum Mol Genet; 2009 Apr; 18(8):1471-81. PubMed ID: 19223393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.
    Zhang F; Bodycombe NE; Haskell KM; Sun YL; Wang ET; Morris CA; Jones LH; Wood LD; Pletcher MT
    Hum Mol Genet; 2017 Aug; 26(16):3056-3068. PubMed ID: 28535287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy.
    Timchenko LT; Timchenko NA; Caskey CT; Roberts R
    Hum Mol Genet; 1996 Jan; 5(1):115-21. PubMed ID: 8789448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
    González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
    PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy.
    Lu X; Timchenko NA; Timchenko LT
    Hum Mol Genet; 1999 Jan; 8(1):53-60. PubMed ID: 9887331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy.
    Leger AJ; Mosquea LM; Clayton NP; Wu IH; Weeden T; Nelson CA; Phillips L; Roberts E; Piepenhagen PA; Cheng SH; Wentworth BM
    Nucleic Acid Ther; 2013 Apr; 23(2):109-17. PubMed ID: 23308382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1.
    Jahromi AH; Fu Y; Miller KA; Nguyen L; Luu LM; Baranger AM; Zimmerman SC
    J Med Chem; 2013 Dec; 56(23):9471-9481. PubMed ID: 24188018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of flexibility in the rational design of modularly assembled ligands targeting the RNAs that cause the myotonic dystrophies.
    Disney MD; Lee MM; Pushechnikov A; Childs-Disney JL
    Chembiochem; 2010 Feb; 11(3):375-82. PubMed ID: 20058255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
    Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
    Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentamidine reverses the splicing defects associated with myotonic dystrophy.
    Warf MB; Nakamori M; Matthys CM; Thornton CA; Berglund JA
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18551-6. PubMed ID: 19822739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (CCUG)
    Yenigun VB; Sirito M; Amcheslavky A; Czernuszewicz T; Colonques-Bellmunt J; García-Alcover I; Wojciechowska M; Bolduc C; Chen Z; López Castel A; Krahe R; Bergmann A
    Dis Model Mech; 2017 Aug; 10(8):993-1003. PubMed ID: 28623239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T.
    Warf MB; Berglund JA
    RNA; 2007 Dec; 13(12):2238-51. PubMed ID: 17942744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1.
    Timchenko NA; Cai ZJ; Welm AL; Reddy S; Ashizawa T; Timchenko LT
    J Biol Chem; 2001 Mar; 276(11):7820-6. PubMed ID: 11124939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy.
    Philips AV; Timchenko LT; Cooper TA
    Science; 1998 May; 280(5364):737-41. PubMed ID: 9563950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
    Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
    Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy.
    Du H; Cline MS; Osborne RJ; Tuttle DL; Clark TA; Donohue JP; Hall MP; Shiue L; Swanson MS; Thornton CA; Ares M
    Nat Struct Mol Biol; 2010 Feb; 17(2):187-93. PubMed ID: 20098426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice.
    Roberts R; Timchenko NA; Miller JW; Reddy S; Caskey CT; Swanson MS; Timchenko LT
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13221-6. PubMed ID: 9371827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs.
    Yuan Y; Compton SA; Sobczak K; Stenberg MG; Thornton CA; Griffith JD; Swanson MS
    Nucleic Acids Res; 2007; 35(16):5474-86. PubMed ID: 17702765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.